MT Newswires
Sanofi Says Subcutaneous Form of Sarclisa for Multiple Myeloma Wins EU Panel Support
âž–
AI Sentiment
Neutral
5/10
Sanofi ADS News
Latest updates and market news for SNY
17 news
Mar 22 - Mar 28, 2026
Page 1
Insider Monkey
FDA Grants Breakthrough Therapy Designation to Venglustat in the US, Sanofi (SNY) Reports
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
How Investors Are Reacting To Regeneron (REGN) Securing Japan’s First Targeted Bullous Pemphigoid Therapy Approval
📊
AI Sentiment
Positive
7/10
Zacks
REGN Soars 28.9% in Six Months: Is There More Upside Potential in 2026?
📊
AI Sentiment
Positive
7/10
Simply Wall St.
Sanofi Autoimmune Pipeline Grows As Market Weighs Valuation And Momentum
📊
AI Sentiment
Positive
7/10
Pharmaceutical Technology
Kali and Sanofi sign licence agreement for KT501 autoimmune disease antibody
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Regeneron, Sanofi's Dupixent Approved in Japan as Bullous Pemphigoid Treatment
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
Press release: Availability of the Q1 2026 aide-mémoire
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
How Apogee, Up 20%, Plans To Take On Rival Regeneron's Eczema Drug
📈
AI Sentiment
Highly Positive
8/10
Pharmaceutical Technology
Earendil Labs lands $787m to fund biologics development push
📈
AI Sentiment
Highly Positive
9/10
PR Newswire
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases
📈
AI Sentiment
Highly Positive
10/10
Simply Wall St.
Sanofi Deepens Mirecule And Earendil Ties To Shape Rare Disease Future
📈
AI Sentiment
Highly Positive
8/10
MarketBeat
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche Milestones, Runway to 2028
📈
AI Sentiment
Highly Positive
9/10
Share this news page